XLF-III-43, a novel coumarin-aspirin compound, prevents diabetic nephropathy in rats via inhibiting advanced glycation end products.
| Image |  |
|---|---|
| Description | scientific article published on 4 November 2009 |
| Author/s |
author: Yi Zhang |
| Publication date | November 4, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |